Assessment of the value of serum cholinesterase as a liver function test for cirrhotic patients
- Authors:
- Fanping Meng
- Xiaojuan Yin
- Xuemei Ma
- Xiao-Dong Guo
- Bo Jin
- Hanwei Li
View Affiliations
Affiliations: Liver Cirrhosis Diagnosis and Therapy Center, 302 Hospital of PLA, Beijing 100039, P.R. China, Affiliated Bayi Children's Hospital, Beijing Military Region General Hospital, Beijing 100700, P.R. China, Pathological Diagnosis and Research Center, 302 Hospital of PLA, Beijing 100039, P.R. China
- Published online on: January 21, 2013 https://doi.org/10.3892/br.2013.60
-
Pages:
265-268
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
A variety of laboratory tests are used in the evaluation of hepatic patients. Serum cholinesterase is reduced in liver dysfunction in contrast to other enzymes. The aim of this study was to assess the value of serum cholinesterase in evaluating liver reserve function in cirrhotic patients. A total of 866 cirrhotic patients were divided into three groups according to their Child-Pugh score. Serum cholinesterase of the patients was detected using the enzyme rate method. Simultaneously, serum albumin was detected using the bromocresol green test, while serum plasma prothrombin time was detected using the clotting assay. Using analysis of variance, the value of serum cholinesterase was analyzed in evaluating the liver reserve function of cirrhotic patients in different Child grades. Using correlation analysis, the correction between cholinesterase and albumin and serum plasma prothrombin time was analyzed. Cirrhotic patients were grouped strictly into A, B and C grades, as per the Child-Pugh score. The results showed that cholinesterase tended to significantly decrease in the three grades Child A (5368.04±1657.32 U/l), Child B (2943.06±1212.84 U/l) and Child C (1832.51±710.68 U/l) (F=264.135, P=0.000). In patients with cirrhosis, cholinesterase was positively correlated with albumin and negatively correlated with serum plasma prothrombin time. In the Child A grade, serum cholinesterase was positively correlated with albumin, but negatively correlated with serum plasma prothrombin time. In the Child B grade, serum cholinesterase remained negatively correlated with serum plasma prothrombin time although there was no significant correlation between cholinesterase and albumin. In the Child C grade, serum cholinesterase positively correlated with albumin, but there was no significant correlation between cholinesterase and serum plasma prothrombin time. In conclusion, correlated with the damage severity of liver cells, cholinesterase may respond to liver reserve function.
View References
|
1
|
Weisinger RA: Laboratory tests in liver
disease and approach to the patient with abnormal test. Cecil
Textbook of Medicine. Goldman L and Bennett JC: 21st edition. WB
Saunders; Philadelphia: pp. 775–777. 2000
|
|
2
|
Vincent D: Transaminases, or
nithinecarbamyl tranferase, arginase, cholinesterase,
etarylesterase. Lyon Med. 232:267–273. 1974.(In French).
|
|
3
|
Zhou X and Tu ZG: Clinical Biological
Chemical and Biological Chemical Inspection. 3rd edition. People’s
Medical Publishing House; Beijing: pp. 325–328. 2003
|
|
4
|
Kariyone K, Shimatani Y, Kurihara T, Nagao
T, Fujita Y and Uesugi M: Establishing indicators for diagnosis of
cholinergic crisis. Rinsho Byori. 58:972–978. 2010.(In
Japanese).
|
|
5
|
Lu Z and Zhong NS: Internal medicine. 7th
edition. People’s Medical Publishing House; Beijing: pp.
4532008
|
|
6
|
Zou Z, Xin S and Li B: Relationship
between cholinesterase, prothrombin activity and albumin and the
pathology of the liver. Zhonghua Shi Yan He Lin Chuang Bing Du Xue
Za Zhi. 15:349–351. 2001.(In Chinese).
|
|
7
|
Association of Infectious and Parasitic
Epidemiology Branch of Learning Branch of Liver Disease: viral
hepatitis prevention and treatment plan. Chin J Inter Med.
40:62–68. 2001.
|
|
8
|
Sinha SN, Keresztes-Nagy S and Frankfater
A: Studies on the distribution of cholinesterases: activity in the
human and dog heart. Pediatr Res. 10:754–758. 2006.PubMed/NCBI
|
|
9
|
Lampert IA and Van Noorden S: Acetyl
cholinesterase is expressed in the follicular dendritic cells of
germinal centres: differences between normal and neoplastic
follicles. J Pathol. 180:169–174. 2006. View Article : Google Scholar
|
|
10
|
Kondo M, Hada T, Fukui T, et al:
Enzyme-linked immunosorbent assay (ELISA) for aleuria aurantia
lectin-reactive serum cholinesterase to differentiate liver
cirrhosis and chronic hepatitis. Clin Chim Acta. 243:1–9. 1995.
View Article : Google Scholar
|
|
11
|
Ogunkeye OO and Roluga AI: Serum
cholinesterase activity helps to distinguish between liver disease
and non-liver disease aberration in liver function tests.
Pathophysiology. 13:91–93. 2006. View Article : Google Scholar
|
|
12
|
McArdle B: The serum cholinesterase in
jaundice and diseases of the liver. Quart J Med. 33:1071940.
|
|
13
|
Wang J, Gao JX and Bai YZ: Patients with
cirrhosis serum cholinesterase clinical research. Chin J Med Lab
Sci. 28:682005.
|
|
14
|
Gu YJ and Zhong YB: Cholinesterase
determination of evaluation of patients with liver cirrhosis of the
liver reserves significance. Chin J Med Guide. 12:649–650.
2010.
|
|
15
|
Prakash R and Mullen KD: Mechanisms,
diagnosis and management of hepatic encephalopathy. Nat Rev
Gastroenterol Hepatol. 7:515–525. 2010. View Article : Google Scholar
|
|
16
|
Chromy V, Sváchová L, Novosád L, et al:
Albumin-based or albumin-linked calibrators cause a positive bias
in serum proteins assayed by the biuret method. Clin Chem Lab Med.
47:91–101. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Garg H, Kumar A, Garg V, Sharma P, Sharma
BC and Sarin SK: Clinical profile and predictors of mortality in
patients of acute-on-chronic liver failure. Dig Liver Dis.
44:166–171. 2012. View Article : Google Scholar : PubMed/NCBI
|
